Every technology commercialisation by start-up creation is a venture.

Entrepreneurs are specialists for ventures.


Michael Weidner



+49 160 97676623

"family name"@1000researchventures.com


Michael strives to combine profitable entrepreneurship with maximum technological, and therefore, societal impact.
He started his first full business aged 24 in the – then profitable – renewable energy industry and achieved more than € 1mn in sales in just two years. Later, while searching for a technology for a new start-up and learning from some of Germany’s leading spin-off entrepreneurs and investors, he noticed a huge gap in public research commercialization. He began to develop entrepreneurial solutions, based on international best practices and shaped, what is now 1000 Research Ventures.
Michael holds a degree in Business Administration from the University of Bayreuth and is very technology-oriented.



Current Advisory Board


Richard Henderson - Managing Partner at MTI Ventures (UK)


After operational roles in industry, Richard has been working with MTI on outstanding research commercialisation since 2001. MTI is an intellectual property investment and company building business, that also manages the £32m UMIP Premier Fund (est. 2008), targeting the University of Manchester and others. The UPF has made investments in areas like novel materials, engineering, energy storage, water, medical diagnostics and IT hardware. The fund’s capital deployment has leveraged £100m of co-investment and has recruited star management from the UK and Europe. Significant exits were realised.



Dr. Valentin Kahl - Founder & CEO of ibidi GmbH (Munich)


Valentin is one of the four founders of ibidi GmbH, a leading provider of innovative functional cell-based assay technologies. Founded as a spin-off from LMU/TU Munich in 2001, ibidi became one of Germany's most successful enabling-technology biotech companies. ibidi received the 2012/2013 German Economy Innovation Award and has over 60 employees today.